These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7586943)

  • 1. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
    O'Shea D; Davis SN; Kim RB; Wilkinson GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms.
    Kim RB; O'Shea D
    Clin Pharmacol Ther; 1995 Jun; 57(6):645-55. PubMed ID: 7781264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
    Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
    Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
    Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
    Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.
    Park JY; Kim KA; Park PW; Ha JM
    J Clin Pharmacol; 2006 Jan; 46(1):109-14. PubMed ID: 16397290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes.
    Draper AJ; Madan A; Latham J; Parkinson A
    Drug Metab Dispos; 1998 Apr; 26(4):305-12. PubMed ID: 9531516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2008 May; 91(5):733-8. PubMed ID: 18672640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.
    Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.
    Leclercq I; Desager JP; Horsmans Y
    Clin Pharmacol Ther; 1998 Aug; 64(2):144-9. PubMed ID: 9728894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of CYP2E1 activity in diabetic rat model].
    Li L; Zhang Y
    Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
    Frye RF; Adedoyin A; Mauro K; Matzke GR; Branch RA
    J Clin Pharmacol; 1998 Jan; 38(1):82-9. PubMed ID: 9597564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans.
    Emery MG; Jubert C; Thummel KE; Kharasch ED
    J Pharmacol Exp Ther; 1999 Oct; 291(1):213-9. PubMed ID: 10490907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.
    Khemawoot P; Yokogawa K; Shimada T; Miyamoto K
    Biochem Pharmacol; 2007 Jan; 73(1):155-62. PubMed ID: 17049493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.
    Liangpunsakul S; Kolwankar D; Pinto A; Gorski JC; Hall SD; Chalasani N
    Hepatology; 2005 May; 41(5):1144-50. PubMed ID: 15841467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.